Sarah Cannon Research Institute to Present at ASCO Gastrointestinal Cancers Symposium.SCRI SCRI Scottish Crop Research Institute (formerly Scottish Horticultural Research Institute, United Kingdom)
SCRI Supercomputer Computations Research Institute
SCRI Steel Can Recycling Institute
SCRI Secure Configuration Remediation Initiative ) physicians authored eight abstracts accepted for presentation at the ASCO ASCO American Society of Clinical Oncology
ASCO Association of Schools and Colleges of Optometry (since 1941; Rockville, Maryland)
ASCO Australian Standard Classification of Occupations
ASCO Automatic Switch Company 2012 Gastrointestinal Cancers Symposium, which runs from Jan. 24-26 in San Francisco, CA.
"The incorporation of targeted therapies in the treatment of gastrointestinal cancers continues to improve clinical outcomes for patients," said Howard A. Burris III, M.D., SCRI's chief medical officer. "We are honored to share results of this important research with leading cancer researchers."
Johanna Bendell, M.D., SCRI's director of gastrointestinal (GI) research and associate director of drug development, Jeffrey Infante in·fan·te
A son of a Spanish or Portuguese king other than the heir to the throne.
[Spanish and Portuguese, both from Latin , M.D., SCRI's director of drug development, and Andrew Kennedy, M.D., SCRI's director of radiation oncology researchwill present the findings of the following studies for oral or poster presentations:
Overview of Targeted Therapies for Esophageal and Gastric Cancers
1/24/13 10:30 am - 12:00 pm; General Session II: Level 2, Ballroom Speaker: Johanna Bendell, M.D.
A randomized, double-blind, placebo-controlled trial of trametinib, a MEK Noun 1. MEK - a terrorist organization formed in the 1960s by children of Iranian merchants; sought to counter the Shah of Iran's pro-western policies of modernization and opposition to communism; following a philosophy that mixes Marxism and Islam it now attacks the inhibitor, in combination with gemcitabine for patients with untreated metastatic Metastatic
The term used to describe a secondary cancer, or one that has spread from one area of the body to another.
Mentioned in: Coagulation Disorders
pertaining to or of the nature of a metastasis. adenocarcinoma adenocarcinoma: see neoplasm. of the pancreas.
1/25/13 12:00 pm - 2:00 pm; General Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Trac, Level 1, West Hall (C39) Lead author: Jeffrey Infante, M.D.
Phase 3 metastatic pancreatic cancer: Randomized phase 3 study of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone in patients with metastatic adenocarcinoma of the pancreas (MPACT MPACT Mississippi Prepaid Affordable College Tuition Plan )
1/25/13 12:00 pm - 2:00 pm and 5:30 pm - 7:00 pm General Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract, Level 1, West Hall (A8); 1/25/13 2:00 pm - 3:30 pm Oral Abstract Session: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract (eQ&A), Level 2, Ballroom Co-author: Jeffrey Infante, M.D.
Phase I/II study of E7050 (golvatinib) in combination with sorafenib in patients with advanced hepatocellular carcinoma: phase I results
1/25/13 12:00 pm - 2:00 pm and 5:30 pm - 7:00 pm General Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Trac, Level 1, West Hall (C42) Co-author: Johanna Bendell, M.D.
Safety and efficacy of resin 90Y-microspheres in 548 patients with colorectal liver metastases Metastasis (plural, metastases)
A tumor growth or deposit that has spread via lymph or blood to an area of the body remote from the primary tumor.
Mentioned in: Malignant Melanoma progressing on systemic chemotherapy.
1/25/13 12:00 pm - 2:00 pm and 5:30 pm - 7:00 pm General Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Trac, Level 1, West Hall (C12) Lead author: Andrew Kennedy, M.D.
Hepatic imaging response to 90Y-microsphere therapy administered for tumor progression during systemic chemotherapy in patients with colorectal liver metastases.
1/25/13 12:00 pm - 2:00 pm and 5:30 pm - 7:00 pm General Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Trac, Level 1, West Hall (C18) Lead author: Andrew Kennedy, M.D.
Phase I study of the HSP (Hosting Service Provider) An organization that specializes in hosting Web sites. There are various levels of offerings from sharing a Web server with several other companies to having a dedicated Web server or to providing co-location services. See co-location. 90 inhibitor AUY922 in combination with capecitabine as treatment for patients with advanced solid tumors.
1/26/13 7:00 am - 7:55 am General Poster Session C: Cancers of Colon and Rectum, Level 1, West Hall (C31) Lead author: Johanna Bendell, M.D.
Effectiveness of Bevacizumab Beyond Disease Progression in Metastatic Colorectal Cancer: Analyses by Sex in the ARIES Aries (âr`ēz) [Lat.,=the ram], constellation lying on the ecliptic (the sun's apparent path through the heavens) between Taurus and Pisces; it is one of the constellations of the zodiac. It contains the bright star Hamal (Alpha Arietis). Observational Cohort Study
1/26/13 7:00 am - 7:55 am and 12:00 pm - 2:00 pm General Poster Session C: Cancers of the Colon and Rectum, Level 1, West Hall (D14) Co-author: Johanna Bendell, M.D.
In addition, Dr. Bendell will be the discussant dis·cus·sant
A participant in a formal discussion.
Noun 1. discussant - a participant in a formal discussion
adducer - a discussant who offers an example or a reason or a proof of a session titled "Cancers of the Esophagus and Stomach" on January 24 from 2:00-3:30 pm on Level 2, in the Ballroom.
About the 2013 Gastrointestinal Cancers Symposium
Celebrating its 10th Anniversary this year, the annual Gastrointestinal (GI) Cancers Symposium is a three-day multidisciplinary meeting that offers the newest strategies in prevention, screening and treatment of gastrointestinal cancers. This multidisciplinary symposium offers educational sessions and abstract presentations focused on each type of GI cancer including cancers of the esophagus, stomach, hepatobiliary tract, pancreas, small bowel, colon and rectum. Co-sponsors of the Symposium include the American Gastroenterological Association (AGA) Institute, the American Society of Clinical Oncology, the American Society for Radiation Oncology and the Society of Surgical Oncology.
Sarah Cannon Research Institute (SCRI) is a global strategic research organization focusing on advancing therapies for patients. It is one of the largest clinical research programs, conducting community-based clinical trials in oncology and cardiology through affiliations with a network of more than 700 physicians in the United States and United Kingdom. Additionally, SCRI offers management, regulatory and other research support services to drug development sponsors and strategic investigator sites. For more information, please visit www.sarahcannonresearch.com.
|Printer friendly Cite/link Email Feedback|
|Date:||Jan 24, 2013|
|Previous Article:||Research and Markets: The Ultimate Connected Car Guide EU (Q4 Update): By 2015 Over 30 Million New Cars Will Be Fitted With Some Type of Connectivity...|
|Next Article:||The Automotive Fine Arts Society to Color the 2013 Amelia Island Concours d'Elegance with Style and Speed.|